MT-CO1 and infection: Our data do not rule out that other mechanisms also may play a role in our model and that COXi treatment during active TB can alleviate excessive inflammation when present, which is in line with decreased bacterial burden in COXi-treated mice after i.v. infection reported herein and by others12–14.